United States Pharmacopoeia (USP) Solutions and Reagents
United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.
Found 7598 products of "United States Pharmacopoeia (USP) Solutions and Reagents"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Methylbis(2-pyridylethyl)amine Hydrochloride (N-Methyl-N,N-bis(2-pyridin-2-yl-ethyl)amine trihydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H19N3·3HClColor and Shape:Light Brown PowderMolecular weight:241.1579Pravastatin Related Compound B (sodium (3R,5R)-3,5-dihydroxy-7-((1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-((S)-2-methylbutanoyloxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoate)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygFormula:C23H36O7Color and Shape:PowderMolecular weight:424.2461N-Nitroso Apixaban Morpholino Pentanoic Acid
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H26N4O5Molecular weight:402.19032Levocabastine Hydrochloride (PLANNED TO BE DISCONTINUED)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C26H29FN2O2·HClColor and Shape:White Off-White PowderMolecular weight:420.22131Glyceryl Monolinoleate
CAS:Oleic, linoleic or linolenic acidsFormula:C21H38O4Color and Shape:Yellow Liquid May Solidify At Room TemperatureMolecular weight:354.27701N-Nitroso Lorcaserin Solution (1 mL )
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C11H13ClN2OMolecular weight:224.07164N-(2,6-Dimethylphenyl)-2-(4-nitrosopiperazin-1-yl)acetamide Solution (1 mL ) (N-(2,6-Dimethylphenyl)-2-(4-nitrosopiperazin-1-yl)acetamide)
<p>Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi</p>Formula:C14H20N4O2Color and Shape:Clear LiquidMolecular weight:276.15863Difluprednate
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C27H34F2O7Molecular weight:508.22726N-Nitroso Propafenone Solution (1 mL )
Compounds with other nitrogen function, nesoiFormula:C21H26N2O4Color and Shape:Colorless LiquidMolecular weight:370.18926Rosuvastatin Ethyl Ester (Ethyl (3R,5S,E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate)
CAS:Sulfonamides, nesoiFormula:C24H32FN3O6SColor and Shape:Off-White PowderMolecular weight:509.19959Dalfampridine Related Compound A (4-Aminopyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C5H6N2OColor and Shape:White SolidMolecular weight:110.04801Modafinil Related Compound B (2-[(diphenylmethyl)sulfonyl]acetamide) (DISCONTINUED)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C15H15NO3SColor and Shape:White PowderMolecular weight:289.07726Probucol Related Compound C (4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol) (DISCONTINUED)
CAS:Other aromatic organo-sulfur compounds (excluding pestiFormula:C31H48O2S2Color and Shape:PowderMolecular weight:516.86Atazanavir Benzylidenehydrazine Carbamate (Methyl [(S)-1-{[(2S,3S)-3-hydroxy-1-phenyl-4-{1-[4-(pyridin-2-yl)benzyl]-2-[4-(pyridin-2-yl)benzylidene]hydrazinyl}butan-2-yl]amino}-3,3-dimethyl-1-oxobutan-2-yl]carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C42H46N6O4Color and Shape:Light Yellow SolidMolecular weight:698.35805Ethylene Sebacate
CAS:Azelaic acid, sebacic acid, their salts and estersFormula:C12H20O4Molecular weight:228.13616Iscotrizinol Related Compound D (2-Ethylhexyl 4-[(4,6-bis{[4-(tert-butylcarbamoyl)phenyl]amino}-1,3,5-triazin-2-yl)amino]benzoate) (DISCONTINUED)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C40H52N8O4Color and Shape:White PowderMolecular weight:708.41115Fentanyl Related Compound B (4-Anilinopiperidine)
CAS:Controlled ProductCompounds containing an unfused pyridine ring in the structure, nesoiFormula:C11H16N2Color and Shape:White PowderMolecular weight:176.13135Lufenuron Related Compound G (2,5-Dichloro-4-[3-(2,6-difluorobenzoyl)ureido]phenyl phenyl carbonate)
CAS:Ureines and their derivatives; salts thereofFormula:C21H12Cl2F2N2O5Color and Shape:PowderMolecular weight:480.00913N-Nitroso N-Methyl Valacyclovir Solution (1 mL )
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C14H21N7O5Molecular weight:367.16042N-Nitroso Desmethyl Escitalopram Solution (1 mL )
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C19H18FN3O2Molecular weight:339.1383Cinnamomum Cassia Twig Powder
CAS:Cinnamon and cinnamon-tree flowers, crushed or groundColor and Shape:Brown Powder2,4,5-Trimethylketoprofen ((2RS)-2-[3-(2,4,5-Trimethylbenzoyl)phenyl]propanoic Acid)
CAS:Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormula:C19H20O3Color and Shape:White Off-White SolidMolecular weight:296.14124Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid)
CAS:Compounds (excluding drugs and pesticides) containing aFormula:C25H30N2O7Color and Shape:PowderMolecular weight:470.2053Oxaliplatin Related Compound B ([SP-4-2-(1R-trans)]-(1,2-cyclohexanediamine-N,N') dinitratoplatinum(II))
CAS:Inorganic or organic compounds of precious metals, whetFormula:C6H14N4O6PtColor and Shape:White Pale Yellow Crystalline PowderMolecular weight:433.05613Dicloxacillin Related Compound D (3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C11H7Cl2NO3Color and Shape:PowderMolecular weight:270.9803Benzoylphenylacetonitrile (3-Benzoylbenzeneacetonitrile)
CAS:Nitrile function compounds, nesoiFormula:C15H11NOMolecular weight:221.08406Ankaflavin
CAS:Lactones, nesoiFormula:C23H30O5Color and Shape:Yellow Dark Yellow PowderMolecular weight:386.20932Protein A (DISCONTINUED)
Diagnostic or lab reagents on a backing, prepared diag/lab reagents whether or not on a backing, not of heading 3002 or 3006; certified ref materialsTetraiodothyroacetic Acid (2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C14H8I4O4Color and Shape:Off-White PowderMolecular weight:747.660152,5-Difluoro Sitagliptin ((3R)-3-Amino-4-(2,5-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]butan-1-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C16H16F5N5OColor and Shape:White Off-White SolidMolecular weight:389.1275Cefmetazole
CAS:Antibiotics nesoiFormula:C15H17N7O5S3Color and Shape:PowderMolecular weight:471.04533Levamlodipine (3-ethyl 5-methyl (S)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C20H25ClN2O5Color and Shape:Off-White SolidMolecular weight:408.1452Thiothixene Related Compound A (N,N-Dimethyl-9-oxo-9H-thioxanthene-2-sulfonamide)
CAS:Sulfonamides, nesoiFormula:C15H13NO3S2Color and Shape:White Off-White Yellow PowderMolecular weight:319.03369Lanolin
CAS:Wool grease, except crude, and fatty substances derived therefrom (including lanolin)Formula:C34H68O2Color and Shape:Yellow SolidMolecular weight:508.9025Chitosan
CAS:Chemical derivatives of natural rubberFormula:(C6H11NO4)xC12H24N209Color and Shape:White Beige Crystalline PowderMolecular weight:1526.454Sulfabenzamide (DISCONTINUED)
CAS:Sulfonamides used as drugsFormula:C13H12N2O3SColor and Shape:PowderMolecular weight:276.05686Phytic Acid Solution (DISCONTINUED)
CAS:Non-aromatic phosphoric esters and their salts, including lactophosphates; their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiColor and Shape:Yellow Brown Liquid ViscousParoxetine Hydrochloride Catechol Analog (4-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzene-1,2-diol, hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C18H20FNO3·HClColor and Shape:Pink SolidMolecular weight:317.14272Linagliptin Enantiomer
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C25H28N8O2Molecular weight:472.23352Drometrizole Trisiloxane Related Compound A (2-(2H-Benzotriazol-2-yl)-6-(isobuten-1-yl)-p-cresol) (DISCONTINUED)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFormula:C17H17N3OColor and Shape:Yellow PowderMolecular weight:279.1371616α-Hydroxyprednisolone ((8S,9S,10R,11S,13S,14S,16R,17S)-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one)
Ketone-alcohols and ketone-aldehydes, nesoiFormula:C21H28O6Color and Shape:White Off-White SolidMolecular weight:376.18859Magnesium Stearate (AS) (DISCONTINUED)
Palmitic acid, stearic acid, their salts and estrsFormula:C18H36O2MgColor and Shape:White PowderIscotrizinol Related Compound I (Bis(2-ethylhexyl) 4,4'-{[6-({4-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)carbamoyl]phenyl}amino)-1,3,5-triazine-2,4-diyl]bis(azanediyl)}dibenzoate) (DISCONTINUED)
Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormula:C55H71N7O7Color and Shape:White PowderMolecular weight:941.5415Desbenzonitrile (S,S)-Isavuconazole
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H14F2N4OSMolecular weight:312.08564Triiodothyroacetic acid ([4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C14H9I3O4Color and Shape:Off-White PowderMolecular weight:621.7635N-Nitroso N-Desmethyl Pheniramine Solution (1 mL )
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C15H17N3OColor and Shape:Colorless LiquidMolecular weight:255.137162,3,5-Trifluoro Sitagliptin Phosphate (3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,3,5-trifluorophenyl)butan-1-one phosphate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C16H15F6N5O·H3PO4Molecular weight:407.11808Eprosartan Related Compound D (4-(bromomethyl)benzoic acid) (DISCONTINUED)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormula:C8H7BrO2Color and Shape:White PowderMolecular weight:213.96294Benzopyrene (Benzo[a]pyrene)
CAS:Cyclic hydrocarbons, nesoiFormula:C20H12Color and Shape:Yellow Green PowderMolecular weight:252.0939Vortioxetine Related Compound H
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C18H22N2SMolecular weight:298.15037Ethylhexyl Triazone Related Compound A (2-ethylhexyl 4-aminobenzoate) (DISCONTINUED)
CAS:Aromatic amino-acids and their esters, other than thoseFormula:C15H23NO2Color and Shape:PlatesMolecular weight:249.17288N-Nitroso Rivaroxaban Openchain Alcohol ((S)-5-chloro-N-(2-hydroxy-3-(nitroso(4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19ClN4O5SColor and Shape:Off-White SolidMolecular weight:438.07647Skim Milk Powder with Maltodextrin Level B (DISCONTINUED)
Milk and cream, concentrated, whether or not sweetened, in powder, granules or other solid forms, fat content not exceeding 1.5%Color and Shape:White Off-White PowderParoxetine Hydrochloride Piperidinemethanol Analog (((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methanol, hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C12H16FNO·HClColor and Shape:Pale Yellow SolidMolecular weight:209.12159Amoxicilloic Acid Dimers 1 and 2
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C32H40N6O11S2Color and Shape:White Off-White SolidMolecular weight:748.21965(S,S,R)-Edoxaban
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H30ClN7O4SMolecular weight:547.17685Collagenase II
CAS:Enzymes and prepared enzymes, nesoiFormula:C5028H7666N1300O1564S21Color and Shape:Colorless LiquidMolecular weight:111953.44286Ticarcillin Monosodium Monohydrate
CAS:Penicillins and their derivatives with a penicillanic acid structure and salts thereof, nesoiFormula:C15H15N2NaO6S2·H2OColor and Shape:PowderMolecular weight:424.42Sildenafil N-Oxide (1-[3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl-4-methylpiperazineN4-oxide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C22H30N6O5SColor and Shape:White SolidMolecular weight:490.19984Rivaroxaban Open Ring ((R)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H20ClN3O4SColor and Shape:Off-White SolidMolecular weight:409.0863Anisyl Butyrate (DISCONTINUED)
CAS:Butyric acid, valeric acid, their salts and estersFormula:C12H16O3Color and Shape:Colorless LiquidMolecular weight:208.10994Lauroyl Arginine (dodecanoylarginine hydrochloride) (DISCONTINUED)
Non-aromatic imines and their derivatives; salts thereof, nesoiFormula:C18H36N4O3·HClColor and Shape:PowderMolecular weight:392.25542Vortioxetine Related Compound I
CAS:<p>Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi</p>Formula:C18H22N2SMolecular weight:298.15037Acalabrutinib Pyrimidinone
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C30H25N7O3Molecular weight:531.20189Deutero N-Nitrosomethylaminobutyric Acid (NMBA-d3) Solution (1 mL )
CAS:Isotopes, except those of hdg 2844; compounds, inorganic or organic, of such isotopes, whether or not chemically defined, nesoiFormula:C5H7D3N2O3Color and Shape:Colorless LiquidMolecular weight:149.08797Zalcitabine Related Compound A (2',3'-Didehydro-2',3'-dideoxycytidine) (DISCONTINUED)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C9H11N3O3Color and Shape:PowderMolecular weight:209.08004Rhodiola Rosea Root and Rhizome Dry Extract
Vegetable saps and extracts, nesoiColor and Shape:Reddish-Brown PowderEpoprostenol Related Compound B (Sodium 5-(diphenylphosphinoyl)pentanoate) (DISCONTINUED)
Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormula:C17H18NaO3PColor and Shape:White PowderMolecular weight:324.08913Erythromycin Gluceptate (DISCONTINUED)
CAS:Erythromycin and its derivatives; salts thereofFormula:C37H67NO13·C7H14O8Color and Shape:CrystalsMolecular weight:959.53011Calcium Folinate (Folic Acid USP Related Compound A, Leucovorin Calcium)
CAS:Formula:C20H21N7O7·CaMolecular weight:471.43 40.08Ref: 4Z-C-466001
Discontinued productN-Nitroso Metformin EP Impurity E Dinitrite (N-Nitroso Metformin USP Related Compound B Dinitrite)
Formula:C3H8N6O·2HNO2Molecular weight:144.14 2*47.01Ref: 4Z-M-4238
Discontinued productKetamine EP Impurity A (E-Isomer) HCl (Ketamine USP Related Compound A (E-Isomer) HCl)
CAS:Formula:C13H16ClNO·HClColor and Shape:White To Off-White SolidMolecular weight:237.73 36.46Ref: 4Z-K-018001
Discontinued productAcetylcysteine EP Impurity D (Acetylcysteine USP Related Compound D)
CAS:Formula:C7H11NO4SColor and Shape:White To Off-White SolidMolecular weight:205.23Ref: 4Z-C-772
Discontinued productRef: 4Z-T-10305
Discontinued productRef: 4Z-T-3411
Discontinued productNicotine USP Related Compound A DiHCl (rac-Nicotine EP Impurity A DiHCl)
CAS:Formula:C10H12N2·2HClColor and Shape:Yellow SolidMolecular weight:160.22 2*36.46Ref: 4Z-N-0640
Discontinued productRef: 4Z-T-10304
Discontinued productNicotine USP Related Compound A-d4 HCl (rac-Nicotine EP Impurity A-d4 HCl)
CAS:Formula:C10H8D4N2·HClColor and Shape:Pale Yellow SolidMolecular weight:164.24 36.46Ref: 4Z-N-063
Discontinued productCarbamazepine EP Impurity D (Carbamazepine USP Related Compound B, Iminostilbene)
CAS:Formula:C14H11NColor and Shape:Yellow SolidMolecular weight:193.25Ref: 4Z-C-1918
Discontinued productNicotine USP Related Compound A (rac-Nicotine EP Impurity A)
CAS:Formula:C10H12N2Color and Shape:Yellow OilMolecular weight:160.22Ref: 4Z-N-0688
Discontinued productReagecon Phloroglucinol TS Solution according to United States Pharmacopoeia (USP)
<p>Reagecon's Phloroglucinol TS Solution according to United States Pharmacopoeia (USP) is specified for use in individual United States Pharmacopoeia (USP) Monographs. It is tested by an ISO 17025 Accredited Test Method (A2LA Ref: 6739.03); is NIST traceable and has guaranteed stability throughout its entire shelf life; even after opening the bottle.</p>Color and Shape:LiquidReagecon pH 6.86 at 25°C Equimolal Phosphate 0.05M according to United States Pharmacopoeia (USP)
<p>Reagecon's pH 6.86 at 25°C Equimolal Phosphate 0.05M according to United States Pharmacopoeia (USP) is specified for use in individual United States Pharmacopoeia (USP) Monographs. It is tested by an ISO 17025 Accredited Test Method (A2LA Ref: 6739.03); is NIST traceable and has guaranteed stability throughout its entire shelf life; even after opening the bottle.</p>Color and Shape:LiquidReagecon Phloroglucinol TS Solution according to United States Pharmacopoeia (USP)
<p>Reagecon's Phloroglucinol TS Solution according to United States Pharmacopoeia (USP) is specified for use in individual United States Pharmacopoeia (USP) Monographs. It is tested by an ISO 17025 Accredited Test Method (A2LA Ref: 6739.03); is NIST traceable and has guaranteed stability throughout its entire shelf life; even after opening the bottle.</p>Color and Shape:LiquidN-Nitroso Methylphenidate EP Impurity A-d5 (Mixture of Diastereomers) (N-Nitroso Methylphenidate USP Related Compound A-d5 (Free Form), N-Nitroso Ritalinic Acid-d5)
Formula:C13H11D5N2O3Molecular weight:253.31Ref: 4Z-M-137032
Discontinued productMethylphenidate EP Impurity A-d5 (Mixture of Diastereomers) (Methylphenidate USP Related Compound A-d5 (Free Form), Ritalinic Acid-d5)
Formula:C13H12D5NO2Molecular weight:224.31Ref: 4Z-M-137031
Discontinued productD-Threo-Methylphenidate EP Impurity A-d9 (D-Threo-Methylphenidate USP Related Compound A-d9 (Free Form), D-Threo-Ritalinic Acid-d9)
Formula:C13H8D9NO2Molecular weight:228.34Ref: 4Z-M-137037
Discontinued productCalcium Folinate-d4 (Folic Acid USP Related Compound A-d4, Leucovorin Calcium-d4)
Formula:C20H17D4N7O7·CaMolecular weight:475.46 40.08Ref: 4Z-C-466003
Discontinued productPrazepam CIV (DISCONTINUED)
CAS:Controlled ProductAlprazolam(inn), camazepam (inn), chlordiazepoxide (inn), clonazepam (inn), clorazepate & other heterocyclic compounds with nitro atom(s) onlyFormula:C19H17ClN2OColor and Shape:PowderMolecular weight:324.10294Diacetylmorphine Hydrochloride CI (AS) (DISCONTINUED)
CAS:Controlled ProductAlkaloids of opium and their derivatives, salts thereof, not elsewhere specified or includedFormula:C21H23NO5·ClHColor and Shape:PowderMolecular weight:405.1343Dimethylamine Solution
CAS:<p>Methylamine, di or trimethylamine and their salts</p>Formula:C2H7N(Dimethylamine)Color and Shape:Colorless LiquidMolecular weight:45.05785Dichloralphenazone CIV (DISCONTINUED)
CAS:Controlled ProductAromatic or modified aromatic compounds containg an unfused pyrazolering (whether or not hydrogenated) in the structureFormula:C11H12N2O·2C2H3Cl3O2Color and Shape:PowderMolecular weight:515.93469Testolactone CIII (DISCONTINUED)
CAS:Controlled ProductAdrenal cortical hormones and their derivatives nesoiFormula:C19H24O3Color and Shape:PowderMolecular weight:300.38 g/molO-Methyl Tapentadol Hydrochloride CII
CAS:Controlled ProductAmino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormula:C15H26ClNOMolecular weight:271.17029
![Moexipril Related Compound A ((3S)-2-{(2S)-N-[(1S)-1-Carboxy-3-phenylpropyl]alanyl}-1,2,3,4-tetrah…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1445608.webp&w=3840&q=75)
